| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb6995de726a2c50bd0b212d33c738fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_076deb4588f5de34f587667dc3b67a42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1be2b34a25e1f0da58a69ae854e38fe4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9404c942873bb55bd85596ffce32ac46 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2799-028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2799-027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2799-022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate |
1996-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84f8ad5b6508445f822f796b5cc61032
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0458451341358de4e720693562834078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa84e646d678b5d68494ed328b49b5db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfac43ca9dfbd4b8e3be8d5e7a36c1a3 |
| publicationDate |
1997-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9717445-A1 |
| titleOfInvention |
Method for treating neurodegenerative diseases using a 1c2 antibody or a fragment or derivative thereof, and corresponding pharmaceutical compositions |
| abstract |
Means for treating and diagnosing neurodegenerative diseases related to the presence of polyglutamine chains by means of a 1C2 antibody are disclosed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0024938-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6844431-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9906545-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9932643-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0008470-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7078191-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8975018-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6630323-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2782167-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0151522-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1252190-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9932643-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6673535-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6291652-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9742314-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1252190-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7595199-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0024938-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011015572-A1 |
| priorityDate |
1995-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |